IHE vs. PBPH
IHE (iShares U.S. Pharmaceuticals ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. Their correlation of 0.89 suggests significant overlap in exposure. IHE charges 0.42%/yr vs 0.13%/yr for PBPH.
Performance
IHE vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IHE achieves a 6.47% return, which is significantly higher than PBPH's -1.13% return.
IHE
- 1D
- 1.16%
- 1M
- 1.80%
- YTD
- 6.47%
- 6M
- 8.51%
- 1Y
- 40.15%
- 3Y*
- 17.47%
- 5Y*
- 9.98%
- 10Y*
- 7.81%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IHE vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 6.47% | -0.51% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between IHE and PBPH is 0.89, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.89 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IHE vs. PBPH — Risk / Return Rank
IHE
PBPH
IHE vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IHE | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.40 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 4.76 | — | — |
| Martin ratioReturn relative to average drawdown | 14.35 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IHE | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.36 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.62 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.43 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | -0.04 | +0.55 |
Drawdowns
IHE vs. PBPH - Drawdown Comparison
The maximum IHE drawdown since its inception was -38.20%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for IHE and PBPH.
Loading charts...
Drawdown Indicators
| IHE | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.20% | -11.10% | -27.10% |
Max Drawdown (1Y)Largest decline over 1 year | -8.47% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -15.92% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -16.03% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -29.59% | — | — |
Current DrawdownCurrent decline from peak | -2.80% | -8.69% | +5.89% |
Average DrawdownAverage peak-to-trough decline | -7.92% | -4.23% | -3.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.81% | — | — |
Volatility
IHE vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| IHE | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.53% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 12.48% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 17.07% | 16.78% | +0.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.24% | 16.78% | -0.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.05% | 16.78% | +1.27% |
IHE vs. PBPH - Expense Ratio Comparison
IHE has a 0.42% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
IHE vs. PBPH - Dividend Comparison
IHE's dividend yield for the trailing twelve months is around 1.65%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.65% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
IHE and PBPH have a correlation of 0.89, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.42% for IHE.
IHE has the higher dividend yield at 1.65%, compared with 0.09% for PBPH.
IHE tracks Dow Jones U.S. Select Pharmaceuticals Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: iShares and Portfolio Building Block. Their fees differ too: 0.42% for IHE and 0.13% for PBPH.
Find the right allocation for IHE and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer